AR056674A1 - ORAL CONTRACEPTION WITH TRIMEGESTONE - Google Patents
ORAL CONTRACEPTION WITH TRIMEGESTONEInfo
- Publication number
- AR056674A1 AR056674A1 ARP060103101A ARP060103101A AR056674A1 AR 056674 A1 AR056674 A1 AR 056674A1 AR P060103101 A ARP060103101 A AR P060103101A AR P060103101 A ARP060103101 A AR P060103101A AR 056674 A1 AR056674 A1 AR 056674A1
- Authority
- AR
- Argentina
- Prior art keywords
- trimegestone
- oral contraception
- contraception
- successive days
- woman
- Prior art date
Links
- JUNDJWOLDSCTFK-MTZCLOFQSA-N trimegestone Chemical compound C1CC2=CC(=O)CCC2=C2[C@@H]1[C@@H]1CC[C@@](C(=O)[C@@H](O)C)(C)[C@@]1(C)CC2 JUNDJWOLDSCTFK-MTZCLOFQSA-N 0.000 title abstract 3
- 229950008546 trimegestone Drugs 0.000 title abstract 3
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 abstract 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 abstract 1
- 229960002568 ethinylestradiol Drugs 0.000 abstract 1
- 230000027758 ovulation cycle Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Método para la anticoncepcion que comprende la administracion de trimegestona junto con etinilestradiol a una mujer en edad fértil en al menos 21 días sucesivos, comenzando el día 1 del ciclo menstrual, en el que en al menos uno de los al menos 21 días sucesivos la dosis diaria de trimegestona es superior a 500 ?g.Method for contraception comprising the administration of trimegestone together with ethinyl estradiol to a woman of childbearing age on at least 21 successive days, beginning on day 1 of the menstrual cycle, in which at least one of the at least 21 successive days the dose Trimegestone daily is greater than 500 µg.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005034498A DE102005034498A1 (en) | 2005-07-20 | 2005-07-20 | Oral contraception with Trimegeston |
| US11/348,545 US20070021396A1 (en) | 2005-07-20 | 2006-02-06 | Oral contraception with trimegestone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR056674A1 true AR056674A1 (en) | 2007-10-17 |
Family
ID=37075980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060103101A AR056674A1 (en) | 2005-07-20 | 2006-07-19 | ORAL CONTRACEPTION WITH TRIMEGESTONE |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1909799A1 (en) |
| KR (1) | KR20080031435A (en) |
| AR (1) | AR056674A1 (en) |
| AU (1) | AU2006271920A1 (en) |
| CA (1) | CA2615427A1 (en) |
| WO (1) | WO2007009769A1 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3888597A (en) * | 1996-07-26 | 1998-02-20 | American Home Products Corporation | Oral contraceptive |
| FR2801218B1 (en) * | 1999-11-23 | 2001-12-28 | Hoechst Marion Roussel Inc | PHARMACEUTICAL COMPOSITIONS COMPRISING TRIMEGESTONE, THEIR PREPARATION METHODS AND THE PRIMARY PACKAGING CONTAINING THEM |
-
2006
- 2006-07-19 AR ARP060103101A patent/AR056674A1/en unknown
- 2006-07-19 WO PCT/EP2006/007103 patent/WO2007009769A1/en not_active Ceased
- 2006-07-19 KR KR1020087004095A patent/KR20080031435A/en not_active Ceased
- 2006-07-19 CA CA002615427A patent/CA2615427A1/en not_active Abandoned
- 2006-07-19 EP EP06762699A patent/EP1909799A1/en not_active Withdrawn
- 2006-07-19 AU AU2006271920A patent/AU2006271920A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2615427A1 (en) | 2007-01-25 |
| KR20080031435A (en) | 2008-04-08 |
| WO2007009769A1 (en) | 2007-01-25 |
| EP1909799A1 (en) | 2008-04-16 |
| AU2006271920A1 (en) | 2007-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP088123A (en) | ORAL CONTRACEPTION WITH TRIMEGESTONE | |
| CR7611A (en) | USE OF CILOTIOCARBAMATE DERIVATIVES IN TREATMENT OF CONDITIONS RELATED TO HORMONE | |
| CO6251259A2 (en) | PHARMACEUTICAL FORMULATIONS OF ESTRIOL IN LOW DOSE | |
| ECSP078066A (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF SYMPTOMS RELATED TO THE CYCLE | |
| AR057060A1 (en) | TANAPROGET COMPOSITIONS CONTAINING ETHYL ESTRADIOL | |
| UY33343A (en) | ORAL SOLID DOSAGE FORMS WITH VERY LOW DOSE FOR HRT | |
| BR0313921A (en) | Estrogen replacement regimen | |
| AR032204A1 (en) | CYCLODEXTRINE-DROSPIRENONE INCLUSION COMPLEXES | |
| HN2008000621A (en) | METHOD FOR PREVENTIVE HORMONAL ANTICOPCEPTION UNDER DEMAND | |
| EA201400202A1 (en) | APPLICATION OF ESTHETROL AS AN EMERGENCY CONTRACTIVE | |
| AR035293A1 (en) | OPHTHALMIC COMPOSITION. | |
| PE20211588A1 (en) | COMPOUNDS AND THEIR USES TO RELIEVE SYMPTOMS ASSOCIATED WITH MENOPAUSE | |
| AR061959A1 (en) | PHARMACEUTICAL COMPOSITION FOR CONTRACEPTION AND TO REDUCE THE RISK OF CONGENITAL MALFORMATIONS | |
| PE20081895A1 (en) | ORAL CONTRACEPTIVE REGIME | |
| ES2563068T3 (en) | Multiple sclerosis (MS) treatment with Campath-1H | |
| ES2574999T3 (en) | Method for contraception on demand using levonorgestrel or norgestrel | |
| AR056674A1 (en) | ORAL CONTRACEPTION WITH TRIMEGESTONE | |
| ECSP099482A (en) | PHARMACEUTICAL PREPARATION TO REDUCE ENDOMETRIOSIS | |
| AR080541A1 (en) | TREATMENT FOR ENDOMETRIOSIS | |
| CL2008002465A1 (en) | Topical anhydrous pharmaceutical composition, comprising niacin derivatives and an acceptable carrier, its application allows improved sexual well-being. | |
| AR049196A1 (en) | HORMONAL CONTRACEPTIVE CONTAINING A COMBINATION OF ETHYLINESTRADIOL AND CLORMADINONE ACETATE | |
| AR129190A1 (en) | NEW MEDICAL USE OF TAFOXYPARIN | |
| UY29861A1 (en) | USE OF ESTRADIOL VALERATE IN COMBINATION WITH DIENOGEST FOR ORAL THERAPY OF THE UNITED DYSFUNCTIONAL UTERINE HEMORRAGY WITH AN ORAL ANTICONCEPTION | |
| CL2023000450A1 (en) | New composition of modified release oral contraceptive | |
| CR9324A (en) | PHARMACEUTICAL PREPARATION FOR ORAL ANTI-CONCEPTION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |